Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment

Front Pharmacol. 2024 Mar 6:15:1345522. doi: 10.3389/fphar.2024.1345522. eCollection 2024.

Abstract

Cancer cells have adapted to rapid tumor growth and evade immune attack by reprogramming their metabolic pathways. Glutamine is an important nitrogen resource for synthesizing amino acids and nucleotides and an important carbon source in the tricarboxylic acid (TCA) cycle and lipid biosynthesis pathway. In this review, we summarize the significant role of glutamine metabolism in tumor development and highlight the vulnerabilities of targeting glutamine metabolism for effective therapy. In particular, we review the reported drugs targeting glutaminase and glutamine uptake for efficient cancer treatment. Moreover, we discuss the current clinical test about targeting glutamine metabolism and the prospective direction of drug development.

Keywords: cancer therapy; combination therapy; glutamine; glutamine metabolism; glutamine uptake.

Publication types

  • Review

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Zhejiang Provincial Natural Science Foundation of China (LY23C100001), the Science and Technology Program of Taizhou City (22gya03), the Taizhou Anti-Cancer Association special research project (TACA-C06). Innovative project for Beihua University graduate (2022026), and MeiKang innovative project for school of medical technology, Beihua University (202302).